Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules

OBJECTIVE: IPX203 is an investigational oral extended-release capsule formulation of carbidopa-levodopa (CD-LD). The aim of this study was to characterize the single-dose pharmacodynamics, pharmacokinetics, and safety of IPX203 in subjects with advanced Parkinson disease compared with immediate-rele...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Neuropharmacol
Главные авторы: Modi, Nishit B., Mittur, Aravind, Rubens, Robert, Khanna, Sarita, Gupta, Suneel
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2019
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654938/
https://ncbi.nlm.nih.gov/pubmed/30520758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WNF.0000000000000314
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы